Method for detecting and modifying mismatches and mutations in nucleic acid
CA 2369470 A1 · Owner: Gotoh, Masanori · Inventors: Whittier, Robert F.; Gotoh, Masanori
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
An objective of this invention is to provide a method for effectively detecting mismatches or mutations in a nucleic acid using MutM protein and a method for effectively separating a nucleic acid with mismatches using MutM protein. MutM protein has been found to be able to recognize any mismatches involving cytosine in a nucleic acid. It has also been found that using the , characteristic of the MutM protein mismatches in a double-stranded nucleic acid can be efficiently detected and a double-stranded nucleic acid with mismatches can be separated from double-stranded nucleic acid samples.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed April 19, 2000. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended April 19, 2020.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by April 19, 2022.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.